Retraction: miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.
APA
Song G, Zhang H, et al. (2025). Retraction: miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.. Oncotarget, 16, 680. https://doi.org/10.18632/oncotarget.28766
MLA
Song G, et al.. "Retraction: miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.." Oncotarget, vol. 16, 2025, pp. 680.
PMID
40879699
같은 제1저자의 인용 많은 논문 (5)
- CCT3 Facilitates the Malignant Progression of NSCLC and SCLC via PI3 K/AKT-EMT Axis and Emerges as a Novel Serum Diagnostic Biomarker.
- Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Soft Tissue Sarcoma Following TKI Treatment Failure: A Retrospective Study.
- Model-based dose selection and pharmacokinetic bridging of subcutaneous from intravenous pembrolizumab across indications.
- Cracking HCC: Targeting diacylglycerol kinase eta to tackle therapy resistance and cancer stemness.
- iRGD Tumor Penetrating Peptide-Modified NK Cells Exhibit Enhanced Tumor Immune Infiltration Ability and Anti-Tumor Efficacy.